| Jill Cassells, CNM | |
|
1548 Main St, Willimantic, CT 06226-1142 | |
| (860) 423-0336 | |
| (860) 423-8428 |
| Full Name | Jill Cassells |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 24 Years |
| Location | 1548 Main St, Willimantic, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912006602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 000213 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
Sanovas Inc., a life science technology company developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has filed with the U.S. Food and Drug Administration for clearance of the company's Vas Zeppelin Smart Catheter for the treatment of chronic pulmonary diseases and lung cancer.
HealthSpring, Inc. announced today that it has priced its underwritten public offering of 7,500,000 shares of its common stock. The shares were resold by the underwriters at a price of $35.95 per share. The Company has also granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock.
Advanced Cardiac Therapeutics, Inc., a developer of innovative temperature-sensing cardiac ablation systems, today announced that the company has received CE Mark (Conformité Européenne) clearance for its TEMPASURE™ cardiac ablation catheter. The TEMPASURE system is the world's first RF cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology.
The Merkin Family Foundation today announced a commitment to the Broad Institute of Harvard and MIT to establish the Merkin Institute Fellows, a program that will support some of the most promising and ambitious scientists pursuing bold research at the Broad Institute.
› Verified 3 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
Sanovas Inc., a life science technology company developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has filed with the U.S. Food and Drug Administration for clearance of the company's Vas Zeppelin Smart Catheter for the treatment of chronic pulmonary diseases and lung cancer.
HealthSpring, Inc. announced today that it has priced its underwritten public offering of 7,500,000 shares of its common stock. The shares were resold by the underwriters at a price of $35.95 per share. The Company has also granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock.
Advanced Cardiac Therapeutics, Inc., a developer of innovative temperature-sensing cardiac ablation systems, today announced that the company has received CE Mark (Conformité Européenne) clearance for its TEMPASURE™ cardiac ablation catheter. The TEMPASURE system is the world's first RF cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology.
The Merkin Family Foundation today announced a commitment to the Broad Institute of Harvard and MIT to establish the Merkin Institute Fellows, a program that will support some of the most promising and ambitious scientists pursuing bold research at the Broad Institute.
› Verified 3 days ago
| Entity Name | Planned Parenthood Of Southern New England Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174633143 PECOS PAC ID: 3173436730 Enrollment ID: O20031110000416 |
News Archive
Sanovas Inc., a life science technology company developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has filed with the U.S. Food and Drug Administration for clearance of the company's Vas Zeppelin Smart Catheter for the treatment of chronic pulmonary diseases and lung cancer.
HealthSpring, Inc. announced today that it has priced its underwritten public offering of 7,500,000 shares of its common stock. The shares were resold by the underwriters at a price of $35.95 per share. The Company has also granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock.
Advanced Cardiac Therapeutics, Inc., a developer of innovative temperature-sensing cardiac ablation systems, today announced that the company has received CE Mark (Conformité Européenne) clearance for its TEMPASURE™ cardiac ablation catheter. The TEMPASURE system is the world's first RF cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology.
The Merkin Family Foundation today announced a commitment to the Broad Institute of Harvard and MIT to establish the Merkin Institute Fellows, a program that will support some of the most promising and ambitious scientists pursuing bold research at the Broad Institute.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jill Cassells, CNM 345 Whitney Ave, New Haven, CT 06511-2348 Ph: (203) 752-2856 | Jill Cassells, CNM 1548 Main St, Willimantic, CT 06226-1142 Ph: (860) 423-0336 |
News Archive
Sanovas Inc., a life science technology company developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has filed with the U.S. Food and Drug Administration for clearance of the company's Vas Zeppelin Smart Catheter for the treatment of chronic pulmonary diseases and lung cancer.
HealthSpring, Inc. announced today that it has priced its underwritten public offering of 7,500,000 shares of its common stock. The shares were resold by the underwriters at a price of $35.95 per share. The Company has also granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock.
Advanced Cardiac Therapeutics, Inc., a developer of innovative temperature-sensing cardiac ablation systems, today announced that the company has received CE Mark (Conformité Européenne) clearance for its TEMPASURE™ cardiac ablation catheter. The TEMPASURE system is the world's first RF cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology.
The Merkin Family Foundation today announced a commitment to the Broad Institute of Harvard and MIT to establish the Merkin Institute Fellows, a program that will support some of the most promising and ambitious scientists pursuing bold research at the Broad Institute.
› Verified 3 days ago